4-Hydroxy-furochromone intermediates for antiathersclerotic comp

Details 4-Hydroxy-furochromone intermediates for antiathersclerotic comp 4-Hydroxy-furochromone intermediates for antiathersclerotic comp

1984-01-03

1985-09-17

Chan, Nicky

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C07D31178

Patent

active

045422281

ABSTRACT:
The present specification provides intermediates for novel analogs of khellin, a natural product, which are useful in the treatment and prevention of atherosclerosis. Particularly, the present disclosure provides novel 5H-furo[3,2-g]-benzopyran-5-ones substituted at the nine position by methoxy and substituted at the four position by hydroxy.

REFERENCES:
patent: 2680119 (1954-06-01), Robertson et al.
patent: 4284569 (1981-08-01), Gammill
patent: 4367341 (1983-01-01), Gammill
Abu-Shady, H., Experiments with Khellin VII., UAR J. Pharm. Sci. 11:283-283, (1970).
Abu-Shady, H., et al., Experiments with Khellin-VIII. J. Pharm. Belg., 33:397-399, (1978).
Anrep, G. V., et al., Therapeutic Uses of Khellin, The Lancet, pp. 557-558, Apr. 26, 1947.
Anrep, G. V., et al., The Coronary Vasodilator Action of Khellin, Amer. Heart J., 37:531-542, (1949).
Apffel, C. A., Die Zytostatische Wirkung von Chinonen und Ihren Derivaten, Deut. Med. Wochschr., 80:414-416, (1955).
Aubertin, E., La Khelline, agent de relachement de la musculature lisse. J. Med. Bordeaux, 127:821-823, (1950).
Baytop, O. T., Khellin'in Yer Solucanlarina Tesiri Hakkinda, Folia Pharm. (Turkey), 1:48-49, (1949).
Best, M. M. et al., Effects of Dioxyline Phosphate and Enteric-Coated Khellin on Coronary Artery Insufficiency, Amer. J. Med. Sci. 222:35-39, (1951).
Chen, G., et al., The Central Nervous Depressive Effect of Khellin, Proc. Soc. Expetl. Biol. Med., 78:305-307, (1951).
Colombo, G., et al., Sulla attivita di alcune sostanze del gruppo della Kellina sulla motilita ureterale--in vitro--, Arch. Sci. Med. 97:71-81, (1954).
Day, C. E., et al., Utility of a Selected Line (SEA) of the Japanese Quail for the Discovery of New Anti-Atherosclerosis Drugs, Laboratory Animal Science, 27:817-821, (1977).
Eaton, R. P., High Density Lipoprotein--Key to Anti-Atherogenesis, J. Chron. Dis., 31:131-135, (1978).
Haust, M. D., Reaction Patterns of Intimal Mesenchyme to Injury, and Repair in Atherosclerosis, Adv. Exp. Med. Biol., 43:35-57, (1974).
Huttrer, C. P., et al., The Chemistry and Physiological Action of Khellin and Related Products, Chem. Revs., 48:543-579, (1951).
Jordan, H., Cardiovasculare Wirkungen Intravenoser Khellin-Injektionen, Arzneimittel-Forsch, 7:82-85, (1957).
LaBarre, J., et al., A propos de l'action inhibitrice de la khelline dans l'ulcere gastrique experimental provoque par administration journaliere de phenylbutazone, Compt. Rend. Soc. Biol., 150:1806-1807, (1956).
Montorsi, W., et al., Sur L'Activite de Certaines Substances du Groupe de la Khelline, Presse Med., 63:81, (1955).
Musante, C., et al., Furil E. Isossazol-Furo-Cromoni e Derivati, Pharmaco. (Pavie) Ed. Sci., 15:81-94, (1960).
Mustafa, A., et al., Experiments with Furochromones, Synthesis of Ammiol and Khellol, J. Org., Chem., 26:886-890, (1961).
Mustafa, A., Furopyrans and Furopyrones, John Wiley and Sons, Inc., NY, (1967), pp. 102-159, (Chapter III: Furochromones).
Osher, H. L., et al., Khellin in the Treatment of Angina Pectoris, New England J. Med., 244:315-321, (1951).
Raymond-Hamet, M., Compt. Rend., 238:1624-1626, (1954).
Samaan, K., et al., The Response of the Heart to Visammin and to Khellinin, J. Pharm. Pharmacol., 1:538-544, (1949).
Samaan, K., et al., The Existence in Ammi Visnaga of a Cardiac Depressant Principle Visammin and a Cardiac Stimulant Glycoside Khellinin, J. Roy. Egypt Med. Assoc., 33:953-960, (1950).
Schonberg, A., et al., Khellin and Allied Compounds, JACS, 72:1611-1617, (1950).
Schonberg, et al., Furo-Chromones and -Coumarins. XIV. JACS, 77:5439-5440, (1955).
Schurr, P. E., High Volume Screening Procedure for Hypobetalipoproteinemia Activity in Rats, Adv. Exp. Med. Biol. 67: Atherosclerotic Drug Discovery, pp. 215-229, Plenum Press, (1975).
Silber, E. N., The Effect of Khellin on Cardio-Pulmonary Function in Chronic Pulmonary Disease, published in 1951, pp. 1046-1054.
Swayne, V. R., et al., Spermicidal Action of Khellin, Amer. J. Pharm., 125:295-298, (1953).

Affiliated with

Also associated with

Rating

4-Hydroxy-furochromone intermediates for antiathersclerotic comp does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-Hydroxy-furochromone intermediates for antiathersclerotic comp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-Hydroxy-furochromone intermediates for antiathersclerotic comp will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-370863